...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Primary Endpoint Results for Phase 3 BETonMACE Cardio Outcomes Trial were Announced September 30th ****Detailed Trial Data to be Presented at AHA Late Breaking Session Nov 16th & Company Webcast Nov 18th******

Free
Discussion Forum: Resverlogix Corp.
Message Title
Rating
Author / Date
1
Nov 20, 2019 05:20AM
1
Nov 20, 2019 03:58AM